Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVolitionRX Ltd Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.83 | -$0.63 | -$0.73 |
| Q2 2026 | 1 | -$0.65 | -$0.49 | -$0.57 |
| Q3 2026 | 1 | -$0.47 | -$0.27 | -$0.38 |
| Q4 2026 | 1 | -$0.34 | -$0.16 | -$0.25 |
| Q1 2027 | 1 | -$0.35 | -$0.17 | -$0.24 |
| Q2 2027 | 1 | -$0.26 | -$0.13 | -$0.18 |
| Q3 2027 | 1 | -$0.21 | -$0.10 | -$0.15 |
| Q4 2027 | 1 | -$0.18 | -$0.09 | -$0.13 |
| Q1 2028 | 1 | $7.39 | $14.85 | $10.41 |
| Q2 2028 | 1 | $7.36 | $14.79 | $10.36 |
| Q3 2028 | 1 | $7.50 | $15.06 | $10.55 |
| Q4 2028 | 1 | $7.98 | $16.03 | $11.23 |
VolitionRX Ltd Earnings Date And Information
VolitionRX Ltd last posted its earnings results on Thursday, August 13th, 2026. The company reported $-0.85 earnings per share for the quarter, missing analysts' consensus estimates of $-0.5675 by $0.2825. The company had revenue of 398.66 K for the quarter and had revenue of 1.73 M for the year. VolitionRX Ltd has generated $-4 earnings per share over the last year ($-4.4 diluted earnings per share) and currently has a price-to-earnings ratio of -0.07. VolitionRX Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
VolitionRX Ltd Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2026 | Q2 2026 | -$0.57 | -$0.85 | -0.28 | $415.25 K | $398.66 K |
| 05/14/2026 | Q1 2026 | -$0.70 | -$0.97 | -0.27 | $1.52 M | $985.08 K |
| 03/31/2026 | Q4 2025 | -$0.80 | -$1.05 | -0.25 | $753.58 K | $447.03 K |
| 11/13/2025 | Q3 2025 | -$0.80 | -$1.00 | -0.2 | $1.68 M | $627.28 K |
| 08/14/2025 | Q2 2025 | -$1.00 | -$1.22 | -0.22 | $417.20 K | $406.69 K |
| 05/15/2025 | Q1 2025 | -$0.86 | -$1.12 | -0.26 | $917.13 K | $246.39 K |
| 03/31/2025 | Q4 2024 | -$1.10 | -$1.32 | -0.22 | $659.00 K | $191.66 K |
| 11/14/2024 | Q3 2024 | -$1.40 | -$1.32 | 0.08 | $652.00 K | $474.52 K |
| 08/14/2024 | Q2 2024 | -$0.09 | -$1.69 | -1.6 | $462.98 K | $395.80 K |
| 05/13/2024 | Q1 2024 | -$1.88 | -$2.00 | -0.12 | $589.52 K | $171.54 K |
| 03/25/2024 | Q4 2023 | N/A | -$2.20 | N/A | $466.67 K | $243.97 K |
| 11/14/2023 | Q3 2023 | -$0.13 | -$2.20 | -2.07 | $356.60 K | $165.21 K |
| 08/14/2023 | Q2 2023 | N/A | -$2.80 | N/A | $271.25 K | $216.31 K |
| 05/10/2023 | Q1 2023 | N/A | -$3.00 | N/A | $417.75 K | $149.81 K |
| 03/15/2023 | Q4 2022 | -$0.15 | -$2.60 | -2.45 | $179.80 K | $119.72 K |
| 11/14/2022 | Q3 2022 | -$0.15 | -$2.80 | -2.65 | $94.34 K | $32.71 K |
| 08/10/2022 | Q2 2022 | -$0.15 | -$2.80 | -2.66 | $110.75 K | $39.75 K |
| 05/11/2022 | Q1 2022 | $0.35 | -$2.80 | -3.15 | $10.02 M | $114.21 K |
| 03/30/2022 | Q4 2021 | -$0.14 | -$3.00 | -2.86 | $16.22 K | $14.24 K |
| 11/10/2021 | Q3 2021 | -$2.00 | -$2.60 | -0.6 | $143.60 K | $25.48 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
VolitionRX Ltd Earnings: FAQ's
The conference call for VolitionRX Ltd's latest earnings report can be listened to online.
The conference call transcript for VolitionRX Ltd's latest earnings report can be read online.
VolitionRX Ltd (:VNRX) has a recorded annual revenue of $1.73 M.
VolitionRX Ltd (:VNRX) has a recorded net income of $-23,357,027.VolitionRX Ltd has generated $-4.4 earnings per share over the last four quarters.
VolitionRX Ltd (:VNRX) has a price-to-earnings ratio of -0.07 and price/earnings-to-growth ratio is -0.